Sanofi SA vs Wheaton Precious Metals Corp — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Wheaton Precious Metals Corp trades at $103.33 (market cap $46.54B). The key difference: Sanofi SA is far larger — about 2.3× Wheaton Precious Metals Corp's market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| SNY | WPM | |
|---|---|---|
Market Cap | $104.83B | $46.54B |
Sector | Health | Basic Materials |
52-Week High | $52.34 | $165.72 |
52-Week Low | $41.33 | $91.00 |
Enterprise Value | $121.32B | $44.39B |
Dividend Yield | 5.5% | 0.75% |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →